viernes, 20 de noviembre de 2026

Multiple sclerosis: beyond controlling relapses The Lancet (++...)

Multiple sclerosis: beyond controlling relapses The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02345-7/fulltext?dgcid=raven_jbs_etoc_email Few neurological diseases have seen a transformation in diagnosis and treatment as remarkable as multiple sclerosis. A chronic, heterogeneous autoimmune condition, it typically begins in early adulthood and affects over 3 million people, with women roughly three times more likely to be affected than men. Characterised by inflammation, demyelination, axonal injury, and neuronal loss, multiple sclerosis can cause relapses and gradual accumulation of disability. Three decades ago, treatment options were few and far between; today, more than 20 disease-modifying therapies are available. These therapies can reduce the frequency of relapses and the development of new lesions detected with MRI. However, the success in controlling relapses has brought to light another challenge: despite otherwise effective treatment, some patients continue to accumulate disability. https://www.thelancet.com/journals/lancet/issue/vol408no10569/PIIS0140-6736(26)X2044-X

No hay comentarios:

Publicar un comentario